{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=EPOCH+II&page=8", "query": { "intervention": "EPOCH II", "page": 8 }, "page_size": 10 }, "pagination": { "page": 8, "page_size": 10, "total_count": 887, "total_pages": 89, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=EPOCH+II&page=9&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=EPOCH+II&page=7&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-15T18:15:01.226Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01642212", "title": "OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Eosinophilic Esophagitis (EoE)" ], "interventions": [ { "name": "Oral Budesonide Suspension (MB-9)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Shire", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "11 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "11 Years to 40 Years" }, "enrollment_count": 93, "start_date": "2012-07-23", "completion_date": "2014-10-30", "has_results": true, "last_update_posted_date": "2021-06-08", "last_synced_at": "2026-11-15T18:15:01.226Z", "location_count": 23, "location_summary": "Phoenix, Arizona • Orange, California • San Diego, California + 17 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Orange", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01642212" }, { "nct_id": "NCT02808975", "title": "Safety and Efficacy of Adalimumab (Humira) for Hidradenitis Suppurativa (HS) Peri-Surgically", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hidradenitis Suppurativa (HS)" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Adalimumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 206, "start_date": "2016-07-18", "completion_date": "2019-10-16", "has_results": true, "last_update_posted_date": "2020-05-14", "last_synced_at": "2026-11-15T18:15:01.226Z", "location_count": 9, "location_summary": "Beverly Hills, California • Encino, California • Irvine, California + 6 more", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "Encino", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "New Orleans", "state": "Louisiana" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02808975" }, { "nct_id": "NCT00103181", "title": "Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "3-dimensional conformal accelerated partial breast irradiation", "type": "RADIATION" }, { "name": "brachytherapy", "type": "RADIATION" }, { "name": "whole breast irradiation", "type": "RADIATION" }, { "name": "MammoSite or other single-entry intracavitary device", "type": "RADIATION" } ], "intervention_types": [ "RADIATION" ], "sponsor": "NSABP Foundation Inc", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 4216, "start_date": "2005-03", "completion_date": "2018-08", "has_results": false, "last_update_posted_date": "2022-04-14", "last_synced_at": "2026-11-15T18:15:01.226Z", "location_count": 374, "location_summary": "Birmingham, Alabama • Peoria, Arizona • Phoenix, Arizona + 295 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00103181" }, { "nct_id": "NCT03800602", "title": "Nivolumab and Metformin in Patients With Treatment Refractory MSS Colorectal Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Colorectal Adenocarcinoma", "Metastatic Microsatellite Stable Colorectal Carcinoma", "Refractory Colorectal Carcinoma", "Stage IV Colorectal Cancer", "Stage IVA Colorectal Cancer", "Stage IVB Colorectal Cancer", "Stage IVC Colorectal Cancer", "Colorectal Cancer Metastatic" ], "interventions": [ { "name": "Metformin", "type": "DRUG" }, { "name": "Nivolumab", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 29, "start_date": "2019-01-15", "completion_date": "2021-09-04", "has_results": true, "last_update_posted_date": "2024-09-05", "last_synced_at": "2026-11-15T18:15:01.226Z", "location_count": 3, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03800602" }, { "nct_id": "NCT06919497", "title": "NOICE vs. Nothing | Thermode", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Spatial Audio Stimulation" ], "interventions": [ { "name": "Spatial audio stimulation", "type": "BEHAVIORAL" }, { "name": "No spatial audio stimulation", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 0, "start_date": "2026-11-01", "completion_date": "2027-09-30", "has_results": false, "last_update_posted_date": "2026-10-28", "last_synced_at": "2026-11-15T18:15:01.226Z", "location_count": 1, "location_summary": "Palo Alto, California", "locations": [ { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06919497" }, { "nct_id": "NCT00003910", "title": "Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Leukemia" ], "interventions": [ { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Methotrexate", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eastern Cooperative Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 59, "start_date": "1999-09-15", "completion_date": "2012-03", "has_results": true, "last_update_posted_date": "2023-07-05", "last_synced_at": "2026-11-15T18:15:01.226Z", "location_count": 68, "location_summary": "Aurora, Colorado • Boulder, Colorado • Colorado Springs, Colorado + 48 more", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Boulder", "state": "Colorado" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Denver", "state": "Colorado" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00003910" }, { "nct_id": "NCT03367923", "title": "Health and Recovery Program in Increasing Physical Activity Level in Stage IA-IIIA Endometrial Cancer Survivors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cancer Survivor", "Endometrial Carcinoma", "Stage I Uterine Corpus Cancer AJCC v7", "Stage IA Uterine Corpus Cancer AJCC v7", "Stage IB Uterine Corpus Cancer AJCC v7", "Stage II Uterine Corpus Cancer AJCC v7", "Stage IIIA Uterine Corpus Cancer AJCC v7" ], "interventions": [ { "name": "Communication Intervention", "type": "OTHER" }, { "name": "Counseling", "type": "OTHER" }, { "name": "Fitbit tracker", "type": "OTHER" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Telephone-Based Intervention", "type": "BEHAVIORAL" } ], "intervention_types": [ "OTHER", "BEHAVIORAL" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 47, "start_date": "2017-12-01", "completion_date": "2020-03-25", "has_results": false, "last_update_posted_date": "2023-11-28", "last_synced_at": "2026-11-15T18:15:01.226Z", "location_count": 2, "location_summary": "Palo Alto, California • San Jose, California", "locations": [ { "city": "Palo Alto", "state": "California" }, { "city": "San Jose", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03367923" }, { "nct_id": "NCT00899574", "title": "Imiquimod for Breast Cancer Patients With Chest Wall Recurrence or Skin Metastases", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Breast Cancer", "Breast Neoplasms" ], "interventions": [ { "name": "Imiquimod", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 10, "start_date": "2009-05", "completion_date": "2013-06", "has_results": true, "last_update_posted_date": "2015-12-07", "last_synced_at": "2026-11-15T18:15:01.226Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00899574" }, { "nct_id": "NCT00916747", "title": "Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Progeria" ], "interventions": [ { "name": "Lonafarnib, Zoledronic Acid, and Pravastatin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boston Children's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 85, "start_date": "2009-08", "completion_date": "2023-12", "has_results": false, "last_update_posted_date": "2023-02-27", "last_synced_at": "2026-11-15T18:15:01.226Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00916747" }, { "nct_id": "NCT00817635", "title": "A Study to Evaluate the Efficacy and Safety of LCI699 Compared to Placebo in Participants With Resistant Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "LCI699", "type": "DRUG" }, { "name": "Eplerenone", "type": "DRUG" }, { "name": "LCI699-matching Placebo", "type": "DRUG" }, { "name": "Eplerenone-matching Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 155, "start_date": "2008-12-22", "completion_date": "2009-10-13", "has_results": true, "last_update_posted_date": "2021-06-02", "last_synced_at": "2026-11-15T18:15:01.226Z", "location_count": 37, "location_summary": "Mobile, Alabama • Sierra Vista, Arizona • Buena Park, California + 34 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Sierra Vista", "state": "Arizona" }, { "city": "Buena Park", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00817635" } ] }